Last reviewed · How we verify
NCT06116981
High-induction Magnetic Field Therapy in Patients With Shoulder Pain
NA trial testing High Induction Magnetic Field Therapy in Rehabilitation in 36 participants. Completed in 2 January 2024.
1 January 2024
Quick facts
| Lead sponsor | KTO Karatay University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 October 2023 |
| Primary completion | 1 January 2024 |
| Estimated completion | 2 January 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- High Induction Magnetic Field Therapy
- Conservative Treatment — full drug profile →
Conditions studied
- Rehabilitation — all drugs for Rehabilitation →
Sponsor
KTO Karatay University
Who can join
Adults 18 to 65, any sex, with Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High Induction Magnetic Field Therapy is a therapeutic method that uses high-intensity fields (up to 2.5 T) that produce high current density in exposed tissue. While there are studies in the literature on devices with 2.5 T, there is no research on the effect of 4 T. Magnetic field application contributes significantly to the healing process. It is an easier, cheaper, and more comfortable application. The magnetic field has been clinically proven to be safe. It is a practical, non-invasive method to induce cell and tissue modifications, correcting selected pathological conditions through magnetic application. The aim of the study is to investigate whether High Induction Magnetic Field therapy applied in addition to conservative treatment in patients with shoulder pain makes a difference compared to conservative treatment alone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06116981
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rehabilitation
Currently open trials in the same condition.
- NCT07450274 — Rehabilitation of Upper Limbs After Stroke · NA · recruiting
- NCT07419217 — Professional Impact of Osteoarticular Trauma · recruiting
- NCT07399262 — Music-Augmented Rhythmic Gait Training in Multiple Sclerosis · NA · recruiting
- NCT07333079 — Rehabilitation With Biofeedback for People After Stroke · NA · recruiting
- NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting
Other KTO Karatay University trials
Trials by the same sponsor.
- NCT07533617 — Chair-Integrated Foam Modifications in Coccydynia · NA · enrolling by invitation
- NCT07532980 — Quadriceps and Hamstring Activation Timing · enrolling by invitation
- NCT07516743 — Acute Effects of Motor Imagery Exercises in Individuals With Pregnancy-Related Lumbopelvic Pain · NA · recruiting
- NCT07487987 — Acute Effects of Motor Imagery and Motor Control Exercises in Individuals With Chronic Neck Pain · NA · recruiting
- NCT07344896 — MBSR Effects on Aging Anxiety and Body Image · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06116981 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by KTO Karatay University
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06116981.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing